Meeder Asset Management Inc Lexicon Pharmaceuticals, Inc. Transaction History

Meeder Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$3.81 - $6.16 $5,848 - $9,455	-1,535 Closed	0 $0
Q2 2021 Aug 09, 2021	BUY	$4.12 - $5.87 $6,324 - $9,010	1,535 New	1,535 $7,000
Q1 2020 May 15, 2020	SELL	$1.8 - $4.28 $17,742 - $42,187	-9,857 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$3.16 - $5.15 $27,507 - $44,830	8,705 Added 755.64%	9,857 $40,000
Q3 2019 Oct 17, 2019	BUY	$1.2 - $6.66 $1,382 - $7,672	1,152 New	1,152 $3,000

141

238M

459K

133K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $157M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.